Levin Easterly Partners LLC Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
16
Insider Buys Sum
$16.09M
Insider Sells Quantity
20
Insider Sells Sum
$19.46M

Insider Activity of Levin Easterly Partners LLC

Biography of Levin Easterly Partners LLC

No biography is available at this moment.

2019-09-17SaleStandard BioTools Inc.
LAB
10 percent owner
577,197
0.455%
$5.40$3.12M-29.82%
2019-09-11SaleStandard BioTools Inc.
LAB
10 percent owner
11,545
0.0094%
$5.55$64,112-29.32%
2019-08-13SaleStandard BioTools Inc.
LAB
10 percent owner
151,011
0.1546%
$7.01$1.06M-42.29%
2019-08-07SaleStandard BioTools Inc.
LAB
10 percent owner
129,237
0.1302%
$6.90$892,060-43.21%
2019-08-01SaleStandard BioTools Inc.
LAB
10 percent owner
1,629
0.0029%
$12.25$19,956-67.7%
2019-07-29SaleStandard BioTools Inc.
LAB
10 percent owner
82,585
0.1443%
$11.97$988,460-67.22%
2019-07-26SaleStandard BioTools Inc.
LAB
10 percent owner
195,982
0.3409%
$11.92$2.34M-67.09%
2019-07-25SaleStandard BioTools Inc.
LAB
10 percent owner
9,405
0.0163%
$11.85$111,480-66.25%
2019-07-24SaleStandard BioTools Inc.
LAB
10 percent owner
28,090
0.0483%
$11.78$330,999-66.55%
2019-07-23SaleStandard BioTools Inc.
LAB
10 percent owner
18,601
0.0314%
$11.58$215,418-65.94%
2019-07-22SaleStandard BioTools Inc.
LAB
10 percent owner
61,432
0.1038%
$11.57$710,903-66.03%
2019-07-19SaleStandard BioTools Inc.
LAB
10 percent owner
83,728
0.1406%
$11.50$963,123-65.88%
2019-07-18SaleStandard BioTools Inc.
LAB
10 percent owner
179,853
0.302%
$11.50$2.07M-65.84%
2019-07-17SaleStandard BioTools Inc.
LAB
10 percent owner
134,487
0.2222%
$11.32$1.52M-65.22%
2019-07-01SaleStandard BioTools Inc.
LAB
10 percent owner
29,410
0.053%
$12.34$362,771-67.41%
2019-06-28SaleStandard BioTools Inc.
LAB
10 percent owner
157,349
0.2826%
$12.30$1.94M-68.18%
2019-06-25SaleStandard BioTools Inc.
LAB
10 percent owner
25,452
0.0455%
$12.23$311,387-67.28%
2019-06-24SaleStandard BioTools Inc.
LAB
10 percent owner
191,696
0.3439%
$12.29$2.36M-67.84%
Total: 18
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.